CFI is continuing the fight against COVID-19. Below is a collection of articles that showcase CFI's efforts.
The Minnesota Daily's Madeline Deninger writes about how Dr. Marc Jenkins and other members of CFI have been working to understand how the body develops antibodies once it has been infected with COVID-19.
CFI director Dr. Marc Jenkins explains how the University of Minnesota and Mayo Clinic are close to unveiling antibody tests that can determine if people have already been infected by the coronavirus that causes COVID-19 and are no longer threats to get or spread the infection. To read the entire Star Tribune article from March 30, 2020 click here.
The Star Tribune's Christopher Snowbeck and CFI's Director Marc Jenkins talk about "a whole new approach to vaccines" using viral RNA instead of the way current vaccines are produced using a weakened or killed form of a virus to stimulate an immune system response that produces antibodies. To read the entire Star Tribune article click here.
Radio and TV
Local News and Seminars
KARE-11 interview with Jennifer Austin on July 14, 2020.
CFI and UMN Collaborators articles
A new vaccine development approach, now being studied at the University of Minnesota Medical School, hopes to protect against current and future strains of SARS-CoV-2 (COVID-19). Drs. Geoffrey Hart and Marco Pravetoni have partnered together to prove that a universal vaccine or antibodies are possible in the fight against future variants of SARS-CoV.
Dr. Tyler Bold explains how sera from patients who have recovered from SARS-CoV-2 infection (convalescent sera) could be used immediately to provide protective immunity.
Dr. Karger discusses the need to create and validate the UMN laboratory-developed tests for COVID-19. Marc Jenkins, PhD, and Fang Li, PhD, had laid the foundation for a new antibody (or serology) test but needed a leader and a lab to bring it up for clinical use. Dr. Karger stepped in.